DK263588D0 - Proterinstof med tnf-virkning - Google Patents

Proterinstof med tnf-virkning

Info

Publication number
DK263588D0
DK263588D0 DK263588A DK263588A DK263588D0 DK 263588 D0 DK263588 D0 DK 263588D0 DK 263588 A DK263588 A DK 263588A DK 263588 A DK263588 A DK 263588A DK 263588 D0 DK263588 D0 DK 263588D0
Authority
DK
Denmark
Prior art keywords
protection
tnf effect
tnf
effect
Prior art date
Application number
DK263588A
Other languages
English (en)
Other versions
DK263588A (da
Inventor
Thomas Doerper
Achim Moeller
Heinz Hillen
Gerhard Keilhauer
Franz Emling
Lothar Daum
Original Assignee
Basf Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Basf Ag filed Critical Basf Ag
Publication of DK263588D0 publication Critical patent/DK263588D0/da
Publication of DK263588A publication Critical patent/DK263588A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/525—Tumour necrosis factor [TNF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/33—Fusion polypeptide fusions for targeting to specific cell types, e.g. tissue specific targeting, targeting of a bacterial subspecies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
    • C07K2319/74—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor
    • C07K2319/75—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor containing a fusion for activation of a cell surface receptor, e.g. thrombopoeitin, NPY and other peptide hormones
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/14—Lymphokine; related peptides
    • Y10S930/144—Tumor necrosis factor

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK263588A 1987-05-16 1988-05-13 Proterinstof med tnf-virkning DK263588A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19873716513 DE3716513A1 (de) 1987-05-16 1987-05-16 Proteine mit tnf-wirkung

Publications (2)

Publication Number Publication Date
DK263588D0 true DK263588D0 (da) 1988-05-13
DK263588A DK263588A (da) 1988-11-17

Family

ID=6327747

Family Applications (1)

Application Number Title Priority Date Filing Date
DK263588A DK263588A (da) 1987-05-16 1988-05-13 Proterinstof med tnf-virkning

Country Status (9)

Country Link
US (1) US5180811A (da)
EP (1) EP0291804A3 (da)
JP (1) JPS63297399A (da)
AU (1) AU600131B2 (da)
DE (1) DE3716513A1 (da)
DK (1) DK263588A (da)
FI (1) FI882283L (da)
HU (1) HU205385B (da)
ZA (1) ZA883428B (da)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2878341B2 (ja) * 1989-03-03 1999-04-05 学校法人藤田学園 人工機能性ポリペプチド
US5780595A (en) * 1989-06-16 1998-07-14 Cor Therapeutics, Inc. Platelet aggregation inhibitors
US5686570A (en) * 1989-06-16 1997-11-11 Cor Therapeutics, Inc. Platelet aggregation inhibitors
US5318899A (en) * 1989-06-16 1994-06-07 Cor Therapeutics, Inc. Platelet aggregation inhibitors
DE3925183A1 (de) * 1989-07-29 1991-02-07 Basf Ag Proteine mit tnf-wirkung
JPH05255393A (ja) * 1990-09-21 1993-10-05 Ishihara Sangyo Kaisha Ltd ポリペプチド
US5519119A (en) * 1990-09-21 1996-05-21 Ishihara Sangyo Kaisha Ltd. Muteins of TNF pharmaceutical compositions and a method of making
US6368815B1 (en) * 1999-03-29 2002-04-09 Warner-Lambert Company Screening of molecules that inhibit human phosphodiesterase 4A produced by non-recombinant cell lines
US20070172449A1 (en) * 2000-03-02 2007-07-26 Xencor, Inc. TNF-alpha VARIANT FORMULATIONS FOR THE TREATMENT OF TNF-alpha RELATED DISORDERS
US7244823B2 (en) * 2000-03-02 2007-07-17 Xencor TNF-alpha variants proteins for the treatment of TNF-alpha related disorders
US7101974B2 (en) 2000-03-02 2006-09-05 Xencor TNF-αvariants
US7687461B2 (en) * 2000-03-02 2010-03-30 Xencor, Inc. Treatment of TNF-α related disorders with TNF-α variant proteins
US7056695B2 (en) 2000-03-02 2006-06-06 Xencor TNF-α variants
US7662367B2 (en) * 2000-03-02 2010-02-16 Xencor, Inc. Pharmaceutical compositions for the treatment of TNF-α related disorders
US7446174B2 (en) 2001-03-02 2008-11-04 Xencor, Inc. Protein based TNF-α variants for the treatment of TNF-α related disorders
GB0209893D0 (en) * 2002-04-30 2002-06-05 Molmed Spa Conjugate
GB0209896D0 (en) 2002-04-30 2002-06-05 Molmed Spa Conjugate
JP4754219B2 (ja) * 2002-12-02 2011-08-24 アムジエン・フレモント・インコーポレイテツド 腫瘍壊死因子を対象とする抗体、およびそれらの使用
KR100755676B1 (ko) * 2005-08-26 2007-09-05 삼성전자주식회사 밝기 향상 및 전력 제어를 지원하는 영상 표시 장치 및방법

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19975063I2 (de) * 1984-03-06 2005-08-18 Dainippon Pharmaceutical Co DNS den menschlichen Tumornekrosisfaktor kodierendund das menschliche Tumornekronisfaktor-Polypepti d.
US4879226A (en) * 1984-04-06 1989-11-07 Asahi Kasei Kogyo Kabushiki Kaisha Novel human physiologically active polypeptide
GB8516421D0 (en) * 1985-06-28 1985-07-31 Biotechnology Interface Ltd Fibronectins
EP0251037B1 (en) * 1986-06-20 1994-06-15 Dainippon Pharmaceutical Co., Ltd. Novel human TNF polypeptide mutants and DNAs encoding said mutants

Also Published As

Publication number Publication date
HUT46946A (en) 1988-12-28
AU1615188A (en) 1988-11-17
DE3716513A1 (de) 1988-11-24
EP0291804A2 (de) 1988-11-23
FI882283A7 (fi) 1988-11-17
FI882283L (fi) 1988-11-17
FI882283A0 (fi) 1988-05-16
AU600131B2 (en) 1990-08-02
ZA883428B (en) 1990-01-31
US5180811A (en) 1993-01-19
HU205385B (en) 1992-04-28
JPS63297399A (ja) 1988-12-05
EP0291804A3 (de) 1990-05-30
DK263588A (da) 1988-11-17

Similar Documents

Publication Publication Date Title
DK521589D0 (da) Cyclopropyl-substituerede dialkyl-forbindelser med insekticid virkning
DK263588A (da) Proterinstof med tnf-virkning
DK187288A (da) Tertiaere arylethylaminderivater med opiatantagonistisk virkning
FI88164C (fi) Metalljonskelat med en kelaterande dipyridoxalfosfatfoerening
DK494887A (da) Fluormiddel med forsinket frigivelse
FI840579A0 (fi) Pipett med reglerbar volym
GB2183235B (en) Substituted benzylhydroxylamines and their use as stabilizers
DK651188A (da) Disulfidholdige pro-laegemidler med antitumorvirkning
FI882238L (fi) Foerbaettringar i samband med organiska foereningar
FI864092A7 (fi) Bruksvagn foersedd med frigoerningsanordning
DK353586A (da) Multistik med afstandsstykker
DK453785D0 (da) Laegemiddel med grf-virkning
NO1997003I1 (no) Tirilazad mezylat
DK124390A (da) Prostaglandinderivater med antitrombotisk virkning
FI88429C (fi) Baeddkaerl i en kraftanlaeggning med foerbraenning i en fluidiserad baedd
SE8702938D0 (sv) Ving-verk med paddeleffekt
SE8404012D0 (sv) Diskhopase med hallare
FI882188A0 (fi) Cylinderlaos med skivformigt skaer
SE8701006D0 (sv) Toalettstolsskydd
SE8704251D0 (sv) Ansiktsskydd med forstoringslupp
SE8401283D0 (sv) Reglerbart batankare med sandskydd
DK198083D0 (da) Konvolut med rivetrad
KR860012087U (ko) 등판
NO168161C (no) Kjoeretoeysete med oppvarming
DK544685D0 (da) Terapeutisk komposition

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment